Literature DB >> 26336550

Defibrillation lead placement using a transthoracic transatrial approach in a case without transvenous access due to lack of the right superior vena cava.

Yosuke Otsuka1, Hideo Okamura2, Syunsuke Sato3, Ikutaro Nakajima1, Kohei Ishibashi1, Kouji Miyamoto2, Takashi Noda1, Takeshi Aiba1, Shiro Kamakura1, Junjiro Kobayashi4, Satoshi Yasuda2, Hisao Ogawa2, Kengo Kusano1.   

Abstract

A 65-year-old woman with a history of syncope was diagnosed with hypertrophic cardiomyopathy. She had previously undergone mastectomy of the left breast owing to breast cancer. Holter electrocardiogram (ECG) and monitor ECG revealed sick sinus syndrome (Type II) and non-sustained ventricular tachycardia. Sustained ventricular tachycardia and ventricular fibrillation were induced in an electrophysiological study. Although the patient was eligible for treatment with a dual chamber implantable cardioverter defibrillator (ICD), venography revealed lack of the right superior vena cava (R-SVC). Lead placement from the left subclavian vein would have increased the risk of lymphedema owing to the patient׳s mastectomy history. Consequently, the defibrillation lead was placed in the right ventricle by direct puncture of the right auricle through the tricuspid valve. The atrial lead was sutured to the atrial wall, and the postoperative course was unremarkable. Defibrillation lead placement using a transthoracic transatrial approach can be an alternative method in cases where a transvenous approach for lead placement is not feasible.

Entities:  

Keywords:  Implantable cardioverter defibrillator; Left superior vena cava; Transthoracic transatrial

Year:  2014        PMID: 26336550      PMCID: PMC4550200          DOI: 10.1016/j.joa.2014.09.003

Source DB:  PubMed          Journal:  J Arrhythm        ISSN: 1880-4276


  8 in total

1.  Persistent left SVC with absent right SVC: a rare anomaly.

Authors:  Vivek Srivastava; Prashant Mishra; Susheel Kumar; Sujit Jana; Jayant Khandekar; Nandlal Agrawal; Anil Madhav Patwardhan
Journal:  J Card Surg       Date:  2007 Nov-Dec       Impact factor: 1.620

2.  Catheterization of a persistent left superior vena cava.

Authors:  Lúcia F Parreira; Carlos C Lucas; Célia C Gil; José D Barata
Journal:  J Vasc Access       Date:  2009 Jul-Sep       Impact factor: 2.283

Review 3.  Breast cancer-related lymphedema.

Authors:  Rosalyn M Morrell; Michele Y Halyard; Steven E Schild; Muna S Ali; Leonard L Gunderson; Barbara A Pockaj
Journal:  Mayo Clin Proc       Date:  2005-11       Impact factor: 7.616

4.  Implantable cardioverter defibrillator lead implantation in patients with a persistent left superior vena cava--feasibility, chances, and limitations: representative cases in adults.

Authors:  M Guenther; S Kolschmann; T P Rauwolf; M Christoph; V Sandfort; R H Strasser; C Wunderlich
Journal:  Europace       Date:  2012-09-19       Impact factor: 5.214

5.  Symptomatic pericardial disease associated with patch electrodes of the automatic implantable cardioverter defibrillator: an underestimated complication?

Authors:  P Chevalier; E Moncada; G Canu; J P Claudel; C Bellon; G Kirkorian; P Touboul
Journal:  Pacing Clin Electrophysiol       Date:  1996-12       Impact factor: 1.976

6.  [Pericardial constriction caused by epicardial patches of automatic implantable defibrillators. Apropos of 3 cases].

Authors:  O Thomas; A Leenhardt; C Masquet; J F Leclercq; M Slama; P Ménasché; P Coumel; R Slama
Journal:  Arch Mal Coeur Vaiss       Date:  1994-07

7.  Surgical options for endocardial lead placement when upper veins are obstructed or nonusable.

Authors:  J Ernesto Molina
Journal:  J Interv Card Electrophysiol       Date:  2004-10       Impact factor: 1.900

8.  Innovative techniques for placement of implantable cardioverter-defibrillator leads in patients with limited venous access to the heart.

Authors:  Bryan C Cannon; Richard A Friedman; Arnold L Fenrich; Charles D Fraser; E Dean McKenzie; Naomi J Kertesz
Journal:  Pacing Clin Electrophysiol       Date:  2006-02       Impact factor: 1.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.